TR1801-ADC in Patients With Tumors That Express c-Met

Clinical trial NCT03859752 · SUSPENDED

Trial details

NCT number: NCT03859752
Sponsor: Open Innovation Partners, Inc.
Status: SUSPENDED
Phase: Phase 1
Study type: INTERVENTIONAL

Unspecified Adult Solid Tumor, Protocol Specific

Start date: 2019-08-14
Primary completion: 2023-07-04
Enrollment: 15

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.